Make a gift

Make a Gift

Donate Now

Cancer Institute

Campaign for Hope

 

 

 

 

 

Since the Cancer Institute's inception in 1994, we have developed a reputation as the leading provider of cancer diagnosis, treatment and research services in the East Tennessee region.

We're proud to be the region's provider of choice for cancer care, but the accompanying increase in cancer services, patient volume, and cancer researchers has outpaced the growth of our physical space. Consequently, patient services are dispersed across the campus which sometimes causes inconvenience or disruptions in care. Research opportunities, and the discoveries that accompany them, are also hindered by our limited physical space.

The Campaign for Hope will increase our physical space by 100% and help us achieve National Cancer Institute designation (NCI). NCI designation will give us the ability to recruit leading cancer experts and researchers to East Tennessee, access the latest therapies, provide more opportunities to participate in clinical trials and research funding through NCI grants.

The Campaign for Hope is a campaign for East Tennesseans. It's a campaign that will mean better facilities, better care, and more opportunities for hope to everyone who's life is touched by cancer in the this region.

 

Campaign Focus

Relocation of Radiation Oncology: The new Cancer Institute will house Radiation Oncology, eliminating the ¼ mile which currently separates it from all other outpatient cancer services. Putting all cancer treatments under one roof will mean increased support, improved coordination of care, and much more ease and convenience for patients throughout their cancer treatment.

$3,000,000.00

New Equipment: State-of-the-art equipment is an absolute necessity in cancer treatment. The Campaign for Hope will provide funding for the most advanced radiation oncology linear accelerators and robotic technology.

$3,000,000.00

Two Endowed Chairs for Cancer Institute: Endowed chairs will help us recruit cancer specialists who are the "best of the best" in both clinical and research areas. These experts can bring the latest treatment techniques to our area and also in turn attract more experts.

$2,000,000.00

Clinical Trials: Clinical research studies provide the only possibility of cure or treatment for certain cancer patients. Funds from the Campaign for Hope will help advance research at the Cancer Institute including Phase I clinical trials and seed funds for new investigations and research projects.

$2,000,000.00

Dollars to be raised

$10,000,000.00

Raised to Date:

$2,521,720

 

Cancer Institute Quick Facts

  • Over 50,000 patient visits each year.
  • Approximately 1,800 new patients are diagnosed and treated each year.
  • Patient visits have increased 46% since 2001.On average, 109 patients are seen each day.
  • Chemotherapy treatments have doubled since 2001.
  • In 2010, 14,227 rounds of chemo were administered, an average of 55 patients a day.
  • Radiation oncology patients averaged 43 per day in 2010.
  • Tumor Registries from 2003-2010 increased 47%.
  • Breast Cancer Referrals have increased by 319% since 2001.
  • An estimated 500,000 free cancer screenings are provided to the community.
  • 2008 and 2011: CoC granted the Institute a 3 year Approval With Commendation.
  • 1 of only 92 facilities nationwide to receive the Outstanding Achievement Award from the CoC in 2008.
  • Has been accredited by the American College of Surgeon's Commission on Cancer (CoC) since 190.
  • 2011 the breast program received accreditation by the Nation Accreditation Program for Breast Centers

For more information about our Cancer Institute Campaign Initiative, please contact the Development Office at 865-305-6611 or development@utmck.edu


 

Contact Development

University of Tennessee Medical Center & UT Graduate School of Medicine
Office of Development
1520 Cherokee Trail, Suite 110, Knoxville, TN 37920-2205
(865) 305-6611
Email us now

 

Committee Members

 

Roger Osborne, Chair

John Bell, MD

Lisa Carroll

Thad Cox

Joan Cronan

Raymond A Dieter, MD

Wahid Hanna, MD

Renee Hawk

Susan N. Huntsinger, MD

Kris Kimball, MD

Brandy Pearl

Bruce Pearl

David Rector

Jeff Roth

Rita Roth

Anne Sprouse

Janet Testerman

Wesley White, MD

O. Lee Wilson, MD

 

Staff Liaisons:

Richard K Giecek, CFRE

J. Katherine Bahr